Experiment: 7ZRO

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D CBCA(CO)NH	0.3 mM [U-13C; U-15N] SEM1(68-107) peptide	90% H2O/10% D2O	0	8.8	1 atm	278	Bruker AVANCE III 700
2	3D C(CO)NH	0.3 mM [U-13C; U-15N] SEM1(68-107) peptide	90% H2O/10% D2O	0	8.8	1 atm	278	Bruker AVANCE III 700
3	3D HNCA	0.3 mM [U-13C; U-15N] SEM1(68-107) peptide	90% H2O/10% D2O	0	8.8	1 atm	278	Bruker AVANCE III 700
4	3D HNCO	0.3 mM [U-13C; U-15N] SEM1(68-107) peptide	90% H2O/10% D2O	0	8.8	1 atm	278	Bruker AVANCE III 700
5	3D HN(CA)CO	0.3 mM [U-13C; U-15N] SEM1(68-107) peptide	90% H2O/10% D2O	0	8.8	1 atm	278	Bruker AVANCE III 700
6	3D HNCACB	0.3 mM [U-13C; U-15N] SEM1(68-107) peptide	90% H2O/10% D2O	0	8.8	1 atm	278	Bruker AVANCE III 700
7	3D 1H-15N TOCSY	0.3 mM [U-13C; U-15N] SEM1(68-107) peptide	90% H2O/10% D2O	0	8.8	1 atm	278	Bruker AVANCE III 700

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	700

NMR Refinement
Method	Details	Software
simulated annealing		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	50
Conformers Submitted Total Number	10
Representative Model	1 (minimized average structure)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CNS		Brunger A. T. et.al.
2	structure calculation	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore
3	chemical shift assignment	CcpNmr Analysis		CCPN
4	processing	TopSpin	3.6	Bruker Biospin

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.